Clinical Trial Update: Aromatase Inhibitor-Associated Musculoskeletal Symptoms in Non-Metastatic, Post Menopausal Breast Cancer Patients

View source ↗

Summary

This ClinicalTrials.gov entry reports a completed study evaluating musculoskeletal symptoms linked to aromatase inhibitors in non-metastatic, postmenopausal bre…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Breast Cancer

Drugs mentioned

• ARIMIDEX (anastrozole)
• Aromasin (exemestane)
• FEMARA (letrozole)

Snippet

Sponsor: Jonsson Comprehensive Cancer Center | Conditions: Breast Cancer | Status: COMPLETED